Supriya Lifescience IPO
subscription is to start from December 16, 2021, Thursday. The company to raise ₹700 crores via IPO at a price band of ₹265 to ₹274. The retail portion of this IPO is 10%, QIB is 75% and HNI is 15% quota. The IPO subscription will close on December 20, 2021, Monday. The minimum bid for the IPO is 54 shares that cost ₹14,796 for 1 lot. The face value is ₹2 per equity share. Supriya Lifescience is a manufacturer of Active pharmaceutical ingredients (APIs). They are consistently one of the largest exporters of Chlorpheniramine Maleate and Ketamine Hydrochloride from India. The company reported ₹396 crores of revenues in 2021 against ₹323 crores in 2020. Please check the Supriya Lifescience IPO details over here.